Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome via colonic mast cell activation and central 5-hydroxytryptamine metabolism

Costunolide not only improved gastrointestinal dysfunction but also ameliorated depressive-like behaviors in mice with stress-induced irritable bowel syndrome.